Advanced in Diabetic Neuropathy

Vincent Rigalleau

CHU De Bordeaux
Bordeaux, FR 
Advanced in Diabetic Neuropathy
CHU De Bordeaux
Bordeaux, FR 
OverviewLocationsClinical Research

Overview

Vincent Rigalleau practices in Bordeaux, France. Mr. Rigalleau is rated as an Advanced expert by MediFind in the treatment of Diabetic Neuropathy. His top areas of expertise are Type 2 Diabetes (T2D), Diabetic Nephropathy, Type 1 Diabetes (T1D), Macrosomia, and Pancreaticoduodenectomy.

His clinical research consists of co-authoring 135 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 7 articles in the study of Diabetic Neuropathy.

Gender
Male

Locations

CHU de Bordeaux
Bordeaux, 33000, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Randomized Trial to Assess the Efficacy of a High-intensity Physical Activity Program on Renal Function Decline in High Risk Patients With Type 2 Diabetes
Randomized Trial to Assess the Efficacy of a High-intensity Physical Activity Program on Renal Function Decline in High Risk Patients With Type 2 Diabetes
Enrollment Status: Terminated
Publish Date: April 09, 2025
Intervention Type: Other
Study Phase: Not Applicable
Management of Diabetic Patients With Neuropathic Osteoarthropathy (Charcot Foot) : Descriptive Study in Diabetic-foot Centers.
Management of Diabetic Patients With Neuropathic Osteoarthropathy (Charcot Foot) : Descriptive Study in Diabetic-foot Centers.
Enrollment Status: Completed
Publish Date: August 09, 2021
Multicentre Double-blind Randomized Clinical Trial Assessing Efficacy and Safety of Exenatide in the Treatment of Hypothalamic Obesity After Craniopharyngioma Therapy
Multicentre Double-blind Randomized Clinical Trial Assessing Efficacy and Safety of Exenatide in the Treatment of Hypothalamic Obesity After Craniopharyngioma Therapy
Enrollment Status: Completed
Publish Date: October 16, 2018
Intervention Type: Drug
Study Phase: Phase 3
View 2 Less Clinical Trials

135 Total Publications

Low serum albumin and severe undernutrition in subjects with diabetes and weight loss.
Low serum albumin and severe undernutrition in subjects with diabetes and weight loss.
Journal: Nutrition (Burbank, Los Angeles County, Calif.)
Published: April 22, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Rigalleau's expertise for a condition
ConditionClose
    View All 8 Advanced Conditions
    View All 19 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile